Newsletter | May 13, 2024

05.13.24 -- Innovating Bioequivalence: A Novel Approach To Developing Complex Generic Dosage Forms

SPONSOR

Pre-Filled Syringes West Coast

Join us at the Pre-Filled Syringes West Coast Conference, June 2024 in San Diego. This pivotal industry gathering focuses on the latest innovations and challenges in the pre-filled syringes sector. Network with key industry leaders, gain insights through in-depth presentations, and explore case studies enhancing drug delivery technology. Don't miss this essential event for professionals in the pharmaceutical and biotechnological fields.

FEATURED EDITORIAL

Innovating Bioequivalence: A Novel Approach To Developing Complex Generic Dosage Forms

Achieving bioequivalence for complex generics is an intricate task. This article describes an approach using in vitro–in vivo correlation, PBMK modeling, and more.

INDUSTRY INSIGHTS

Leveraging Autoinjector Innovation To De-Risk Biosimilar Development

Discover how a biopharmaceutical company can de-risk the launch process by choosing a suitable autoinjector technology and partner.

The Path To Self-Administration: Moving From PFS To Auto-Injector

Review advice to pharma companies on three key areas of auto-injector device development: patient-centered design, container and device considerations, and manufacturing partner selection.

Is My Molecule Suitable For An Orally Disintegrating Tablet?

Innovations in drug delivery formats are enabling more patient-centric treatments and helping to boost patient compliance. Learn about the advances expanding the potential of ODT technology.

The Changing Landscape Of Wearable Drug Containment And Delivery

By partnering with a delivery system manufacturer early, manufacturers can move to market with a commercially viable delivery system and gain valuable insight into the drug product along the way.

Kinetisol Technology: Broader. Faster. Greener.

Explore how a solvent-free alternative for the production of amorphous solid dispersions (ASDs) not only improves manufacturability but also reduces the carbon footprint of ASD manufacturing.

SOLUTIONS

Glass Prefillable Syringe Solution Delivering Complex Biologics

Autoinjector For Deep Intramuscular Delivery